Author: Dent Gordon
Publisher: Informa Healthcare
ISSN: 1354-3776
Source: Expert Opinion on Therapeutic Patents, Vol.13, Iss.10, 2003-10, pp. : 1607-1617
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Anti-IgE Therapy in Allergic Asthma
Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 5, 2005-10 ,pp. :
IgE, Allergic Diseases, and Omalizumab
Current Pharmaceutical Design, Vol. 12, Iss. 30, 2006-10 ,pp. :
Anti-IgE monoclonal antibody E25 beneficial in allergic asthma
Inpharma, Vol. 1, Iss. 1220, 2000-01 ,pp. :